: Rubia highlights that ADHD is the most-imaged child psychiatric disorder. Research consistently shows small but reliable differences in the structure and functional connections of frontal, parietotemporal, and striatal brain regions.
The article is frequently cited in discussions about the limitations of current ADHD drug therapies, which often lack long-term safety evidence and may be less preferred by parents and clinicians than non-pharmacological alternatives. Rubia (2022)
For a deep dive into the specific data on fMRI-NF protocols, you can access the full article on Wiley Online Library . : Rubia highlights that ADHD is the most-imaged
The request likely refers to the academic review article published by Katya Rubia in the journal Psychiatry and Clinical Neurosciences in 2022. Article Overview For a deep dive into the specific data
Most studies have been small with heterogeneous designs, often testing effects on cognitive functions rather than clinical symptoms.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Neurotherapeutics for ADHD: Do they work? - Rubia - 2022
: Rubia suggests that "one-size-fits-all" approaches are likely to fail. Future success depends on personalizing treatment based on a patient’s neurocognitive or brain-imaging patterns. Clinical Context